Welcome to LookChem.com Sign In|Join Free

CAS

  • or

929411-71-2

6-bromo-N-(3-fluorophenyl)quinazolin-4-amine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

929411-71-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 929411-71-2 Structure

  • Basic information

    1. Product Name: 6-bromo-N-(3-fluorophenyl)quinazolin-4-amine
    2. Synonyms: 6-bromo-N-(3-fluorophenyl)quinazolin-4-amine
    3. CAS NO:929411-71-2
    4. Molecular Formula:
    5. Molecular Weight: 318.148
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 929411-71-2.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 6-bromo-N-(3-fluorophenyl)quinazolin-4-amine(CAS DataBase Reference)
    10. NIST Chemistry Reference: 6-bromo-N-(3-fluorophenyl)quinazolin-4-amine(929411-71-2)
    11. EPA Substance Registry System: 6-bromo-N-(3-fluorophenyl)quinazolin-4-amine(929411-71-2)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 929411-71-2(Hazardous Substances Data)

929411-71-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 929411-71-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,9,4,1 and 1 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 929411-71:
(8*9)+(7*2)+(6*9)+(5*4)+(4*1)+(3*1)+(2*7)+(1*1)=182
182 % 10 = 2
So 929411-71-2 is a valid CAS Registry Number.

929411-71-2Downstream Products

929411-71-2Relevant articles and documents

Design, synthesis and biological evaluation of novel 4-aminoquinazolines as dual target inhibitors of EGFR-PI3Kα

Ding, Huai-Wei,Deng, Cheng-Long,Li, Dan-Dan,Liu, Dan-Dan,Chai, Shao-Meng,Wang, Wei,Zhang, Yan,Chen, Kai,Li, Xin,Wang, Jian,Song, Shao-Jiang,Song, Hong-Rui

, p. 460 - 470 (2018/02/14)

The overexpression of EGFR correlates with rapidly progressive disease, resistance to chemotherapy and poor prognosis. In certain human cancers, PI3K works synergistically with EGFR to promote proliferation, survival, invasion and metastasis. Development

Synthesis and in vitro cytotoxicity of the 4-(Halogenoanilino)-6-bromoquinazolines and their 6-(4-fluorophenyl) substituted derivatives as potential inhibitors of epidermal growth factor receptor tyrosine kinase

Mphahlele, Malose Jack,Paumo, Hugues K.,Choong, Yee Siew

, (2017/12/05)

Series of the 2-unsubstituted and 2-(4-chlorophenyl)–substituted 4-anilino-6-bromoquinazolines and their 6-(4-fluorophenyl)–substituted derivatives were evaluated for in vitro cytotoxicity against MCF-7 and HeLa cells. The 2-unsubstituted 4-anilino-6-brom

Discovery, synthesis, and biological evaluation of thiazoloquin(az)olin(on)es as potent CD38 inhibitors

Haffner, Curt D.,Becherer, J. David,Boros, Eric E.,Cadilla, Rodolfo,Carpenter, Tiffany,Cowan, David,Deaton, David N.,Guo, Yu,Harrington, Wallace,Henke, Brad R.,Jeune, Michael R.,Kaldor, Istvan,Milliken, Naphtali,Petrov, Kim G.,Preugschat, Frank,Schulte, Christie,Shearer, Barry G.,Shearer, Todd,Smalley, Terrence L.,Stewart, Eugene L.,Stuart, J. Darren,Ulrich, John C.

, p. 3548 - 3571 (2015/05/05)

A series of thiazoloquin(az)olinones were synthesized and found to have potent inhibitory activity against CD38. Several of these compounds were also shown to have good pharmacokinetic properties and demonstrated the ability to elevate NAD levels in plasm

Discovery and SAR of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of mGlu5

Felts, Andrew S.,Saleh, Sam A.,Le, Uyen,Rodriguez, Alice L.,Weaver, C. David,Conn, P. Jeffrey,Lindsley, Craig W.,Emmitte, Kyle A.

scheme or table, p. 6623 - 6626 (2010/06/12)

A high-throughput cell-based screen identified a series of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of metabotropic glutamate receptor 5 (mGlu5). This Letter describes the SAR of this series and the profile of selected

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 929411-71-2